Where the stock stands
AKUMS trades at a price-to-earnings ratio of 37.47 and a price-to-book ratio of 2.89, with earnings per share of 16.67 and return on equity of 8.0%. The market capitalisation stands at ₹9,562 crore, and the dividend yield is 0.16%. The Nifty moved 0.66% on the session.
What the smart-money flow shows
The evidence pack contains no data on futures and options positioning, including open interest changes, long or short buildup, or cost-of-carry figures. No bulk deals or block deals are recorded. There are no named institutional transactions, no streak of foreign or domestic institutional buying or selling, and no recent insider filings to report. The data shows no recent insider filings.
The technical picture
No technical indicators — such as moving averages, support and resistance levels, relative strength index, or volume trends — are provided in the evidence pack. The data is silent on chart patterns or price action beyond the valuation metrics listed.
Catalysts and what to watch
According to a headline from NSE dated 6 July 2026, the Deputy Commissioner of State Tax, Gujarat, imposed a penalty on Maxcure Nutravedics Limited, a wholly owned subsidiary of the company. The same headline, with identical wording, was reported on 5 July and 4 July 2026. No other corporate events, analyst rating changes, or scheduled disclosures are listed. The data does not establish the size of the penalty, the current status of any appeal, or whether the matter is material to consolidated earnings. What the data does establish is limited to the existence of this regulatory action and the valuation multiples at which the stock currently trades.